Mahajan brings more than 20 years of global finance and leadership experience across healthcare, pharmacy and financial services organizations
Prime’s IntegratedRx® model brings pharmacists and providers together to improve care and reduce costs
Payne to integrate communications, government affairs and policy efforts at leading purpose-driven, transparent PBM
New approach aligns with long-standing biosimilar strategy
Research on GLP-1 drugs, specialty therapies and more helps improve affordability in health care
Accelerated platform deployment meets rising demand for pharmacy innovation
Findings also show improved persistence with high-potency,
obesity-approved GLP-1 products
Prime to present seven studies and receive the 2024 JMCP Award for Excellence
Real-world study of GLP-1 patients continues to deliver leading insights
Prime’s signature report — with its deep insights and forecasting — recognized in health care industry as credible source to inform payer strategies
Studies include Prime’s GLP-1 obesity research, the impact of social determinants of health and more.